참고문헌
- Joint Task Force on Practice Parameters. Allergen immunotherapy: A practice parameter. american academy of allergy, asthma and immunology. american college of allergy, asthma and immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl):1S-40S
- Sturm G, Kranke B, Rudolph C, Aberer W. Rush hyrnenoptera venom immunotherapy: A safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110:928-33 https://doi.org/10.1067/mai.2002.129124
- Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. J Investig Allergol Clin Immunol 2006;16:79-85
- Birnbaum J. Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): A safety study and risk factors. Clin Exp Allergy 2003;33:58-64 https://doi.org/10.1046/j.1365-2222.2003.01564.x
- Scribner TA, Bernstein DI. Rapid venom immunotherapy update. Curr Opin Allergy Clin Immunol 2003;3:295-8 https://doi.org/10.1097/00130832-200308000-00010
- van der Brempt X, Ledent C, Mairesse M. Accelerated desensitization for hymenoptera venom allergy in 30 hours: Efficacy and safety in 150 cases. Rev Med Brux 1997;18:120-4
- Schiavino D, Nucera E, Pollastrini E, De Pasquale T, Buonomo A, Bartolozzi F, et al. Specific ultrarush desensitization in hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol 2004;92:409-13 https://doi.org/10.1016/S1081-1206(10)61775-9
- Birnbaum J. Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): A safety and risk factors. Clin Exp Allergy 2003;33:58-64 https://doi.org/10.1046/j.1365-2222.2003.01564.x
- Hirokawa Y, Kondo T, Kobayashi I, Ohta Y. Rush immunotherapy with house dust extract in patients with mild extrinsic asthma. Tohoku J Exp Med 1996;178:371-80 https://doi.org/10.1620/tjem.178.371
- Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized dermatophagoides pteronyssinus extract. IV. systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473-9 https://doi.org/10.1016/0091-6749(90)90157-Y
- Akmanlar N, Altintas DU, Guneser KS, Yilmaz M, Bingol G. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy. Allergol Immunopathol (Madr) 2000;28:213-8
- Litvyakova LI, Baraniuk JN. Nasal provocation testing: A review. Ann Allergy Asthma Immunol 2001;86:355-64 https://doi.org/10.1016/S1081-1206(10)62478-7
- Sharkey P, Portnoy J. Rush immunotherapy: Experience with a one-day schedule. Ann Allergy Asthma Immunol 1996;76:175-80 https://doi.org/10.1016/S1081-1206(10)63419-9
- Casanovas M, Martin R, Jimenez C, Caballero R, Fernandez-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol 2006;139:153-8 https://doi.org/10.1159/000090392
- Golden DB, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of hymenoptera venom immunotherapy. Ann Intern Med 1980;92:620-4 https://doi.org/10.7326/0003-4819-92-5-620
- Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(1 Suppl):47S-55S https://doi.org/10.1016/S1081-1206(10)62195-3
- Ibero M, Castillo MJ Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol 2006;16:194-202
- Tabar AI, Fernandez-Tavora L, Alonso R, Castillo R, Cistero-Bahima A, de la Torre-Morin F, et al. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: Multicentre study. J Investig Allergol Clin Immunol 2004;14:193-7
- Nagata M, Yamamoto H, Tabe K, Kimura I, Houya I, Kuramitsu K, et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: Changes in in vivo and in vitro responses to HDM. Intern Med 1993;32:702-9 https://doi.org/10.2169/internalmedicine.32.702
- Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;4:CD001186
- Boquete M, Carballada F, Exposito F, Gonzalez A. Preventive immunotherapy. Allergol Immunopathol (Madr) 2000;28:89-93
- Kohno Y, Minoguchi K, Oda N, Yokoe T, Yamashita N, Sakane T, et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J Allergy Clin Immunol 1998;102(6 Pt 1):927-34 https://doi.org/10.1016/S0091-6749(98)70330-6
- Le Roux P, Le Luyer B. Accelerated desensitization to dermatophagoides pteronyssinus mites in children with asthma. results of two years of immunotherapy. Allerg Immunol (Paris) 1991;23:135-42
- Paty E, de Blic J, Brunet D, Le Bourgeois M, Garcelon M, Paupe J, et al. Accelerated desensitization with dermatophagoides pteronyssinus in severe asthmatic children. evaluation after one year of immunotherapy. Arch Fr Pediatr 1990;47:173-9
- Tabar AI, Echechipia S, Garcia BE, Olaguibel ]M, Lizaso MT, Gomez B, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with dermatop-hagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-18 https://doi.org/10.1016/j.jaci.2005.05.005
- Nanda A, O'connor M, Anand M, Dreskin SC, Zhang L, Hines B, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004;114:1339-44 https://doi.org/10.1016/j.jaci.2004.08.049
피인용 문헌
- Safety of ultrarush immunotherapy vol.5, pp.6, 2008, https://doi.org/10.4168/aard.2017.5.6.305
- Safety of ultrarush allergen subcutaneous immunotherapy in children with allergic disease vol.5, pp.6, 2008, https://doi.org/10.4168/aard.2017.5.6.336
- Research on pediatric allergic rhinitis in Korea vol.6, pp.suppl1, 2008, https://doi.org/10.4168/aard.2018.6.s1.s58